Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zosuquidar in Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Anemia
NCT00046930Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Sep 2002
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) comparing Zosuquidar with Placebo (2 arms). Primary endpoint: Overall Survival. Started Sep 2002; status: completed.
02
Drugs
zosuquidar
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00046930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046930.